Behavioral Neuroscience – News and Features

National Genome Research Network has purchased Affymetrix’s Genome-Wide Human SNP Array 5.0 to genotype 17,000 individuals in a study of 25 diseases.

The megNet® software can be applied in understanding complex relations in living organisms, and characterizing various diseases, such as cardiac diseases and diabetes.

Scientists at NGFN will genotype 8,000 patients using Illumina's tools to investigate genetic variations to better understand causes of 25 complex diseases.

A multi-million pound visionary medical project that will recruit 500,000 people across Britain to help find out much more about curing many life threatening and debilitating diseases gets underway in Manchester.

Psychiatric researchers used HelixTree® Genetics Analysis Software to uncover evidence of a novel genetic locus that appears to increase the risk of developing schizophrenia.

Millipore has acquired an exclusive worldwide license to distribute the ENStem neural progenitor cells derived from NIH-registered human embryonic stem cells.

Broad Institute receives $100M gift from Stanley Medical Research Institute to study the genomics and chemical biology of schizophrenia, bipolar disorder.

VAI and Spectrum Health announce a molecular technologies lab that will study genomics and proteomics for application in cancer, heart disease, mental illness, and other diseases.

CombiMatrix will create an array-based test using biomarkers linked to autism that were developed by the Center for Applied Genomics.

Clinical Data’s PGxPredict:CLOZAPINE™ test will aid physicians in determining patients’ risk for developing agranulocytosis.